Live Breaking News & Updates on Developmental Neuroscience Programme

Stay updated with breaking news from Developmental neuroscience programme. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Stoke Therapeutics (STOK) Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome

Stoke Therapeutics (STOK) Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , United-kingdom , Orlando , Florida , American , Helen-cross , Joseph-sullivan , Barry-ticho , Archana-desurkar , University-of-california-san-francisco , Pediatric-epilepsy-center , Nasdaq

Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome at the American Epilepsy Society (AES) 2023 Annual Meeting

– Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support. ....

United-kingdom , United-states , Massachusetts , Bedford , Orlando , Florida , Cambridge , Cambridgeshire , American , Helen-cross , Joseph-sullivan , Barry-ticho

Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndr

– Data from clinical studies of STK-001 demonstrated clinical benefit for patients ages 2 to 18 years old, including reductions in seizures and improvements in cognition and behavior that support the potential for disease modification –– Analysis of 72 patients treated in STK-001 clinical trials suggests that higher. ....

United-kingdom , Massachusetts , United-states , Orlando , Florida , Bedford , Cambridge , Cambridgeshire , American , Helen-cross , Joseph-sullivan , Archana-desurkar

Stoke Therapeutics to Present Data from the Company's Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting -November 21, 2023 at 08:05 am EST

– New data include 24-month results from the largest and longest prospective natural history study of children and adolescents with Dravet syndrome, which showed a lack of improvement despite. ....

United-kingdom , Massachusetts , United-states , Cambridge , Cambridgeshire , Florida , Orlando , Bedford , American , Helen-cross , Joseph-sullivan , Archana-desurkar

Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Treatment of Dravet Syndrome at the 35th International Epilepsy Congress

DUBLIN (BUSINESS WIRE) Sep 5, 2023 ....

United-kingdom , Bedford , Massachusetts , United-states , Ireland , Cambridge , Cambridgeshire , Dublin , Helen-cross , Im-scott-perry , Elaine-wirrell , Eric-rojas